ClinicalTrials.gg
Drug

Drospirenone clinical trials

studies test it
33
open now
5
in phase 3
9
first study started
2005

How each study uses drospirenone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the drospirenone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
11 May 2001 · YASMIN · NDA 021098 (FDA, Drugs@FDA; in a combination)
European Union
19 May 2021 · Drovelis · EMEA/H/C/005336 (EMA; in a combination)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Drospirenone
6

Development codes

CF111
1

In one entry with another drug

Given together, or one or the other

15 mg E4/3 mg DRSP
5
15 mg estetrol and 3 mg drospirenone
3
Drospirenone and ethinyl estradiol
2
0.25mg DRSP / 0.5mg E2 (BAY86-4891)
2
Estradiol/DRSP (Angeliq, BAY86-4891)
2
30 mcg ethinylestradiol/3 mg drospirenone
2

Studies by the year they started

33 studies that test it; most in 2007 (4)

Studies that test drospirenone, by start year
YearStudies
20051
20061
20074
20084
20092
20101
20121
20131
20141
20152
20163
20171
20181
20222
20232
20244
20262

By phase

A phase 1/2 study counts in both.

Phase 1
7
Phase 2
6
Phase 3
9
Phase 4
10
No phase
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 19 · Other 14

Estetra (6) · Bayer (6) · Massachusetts General Hospital (3) · Insud Pharma (2) · Chulalongkorn University (2) · NewAmsterdam Pharma (1) · Eli Lilly and Company (1) · University of Palermo (1)

Often tested with

Tested in the same studies.

Ethinyl Estradiol (12) · Estetrol (8) · Estradiol (8) · Dienogest (2) · TA-8995 (1) · Retatrutide (1) · Nomegestrol acetate (1) · Norgestimate (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test drospirenone.

Studies

Open first, then newest update. How each study uses drospirenone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 33

See all 33 studies that test drospirenone →

Given beside what is tested · 22 — drospirenone is usual care or a partner of the new treatment

Showing 20 of 22.

As the comparator · 5 — what is tested is compared with drospirenone

Codes

What other systems call drospirenone · ClinicalTrials.gg INT003045

  • MeSH (NLM) C035144drospirenoneConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) N295J34A25DROSPIRENONEConfirmed FDA, NLM, Wikidata
  • RxNorm 11636Confirmed FDA, Wikidata
  • Wikidata Q419646drospirenoneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C47502DrospirenoneOne source FDA
  • DrugBank DB01395One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.